China Should Not Be Overlooked By Smaller Device Firms, Consultant Says
This article was originally published in The Gray Sheet
Smaller device firms with technology commercialized in the U.S. or Europe should consider the supplemental revenue opportunity presented by China, says Synaptic Medical CEO Sophia Wang
You may also be interested in...
Approval time for device manufacturers aspiring to enter the China market can be cut in half if the product already is 510(k)-cleared, according to Bridgetech Holdings International CEO Michael Chermak
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.